Among the four genes included in the signature, NAT2 (N-acetyltransferase 2), as an important two-phase metabolic enzyme, exhibits evident genetic polymorphism and is considered to be strongly associated with CRC genetic susceptibility (26, 27). Here, NAT2 is linked to colorectal carcinoma.